Hubei Huaqiang High-Tech Co. Ltd. A

SHG:688151 China Medical Instruments & Supplies
Market Cap
$1.03 Billion
CN¥7.54 Billion CNY
Market Cap Rank
#14017 Global
#3649 in China
Share Price
CN¥21.90
Change (1 day)
+0.46%
52-Week Range
CN¥15.23 - CN¥28.19
All Time High
CN¥42.75
About

Hubei Huaqiang High-Tech Co., Ltd. research, develops, produces, and sells special protective equipment, pharmaceutical packaging, and medical devices in China. It operates as a chemical defense military enterprise in special protection. The company offers personal protective equipment, such as anti-virus clothing and boot covers, and gas masks; collective protective equipment, comprising coopera… Read more

Hubei Huaqiang High-Tech Co. Ltd. A (688151) - Net Assets

Latest net assets as of June 2025: CN¥4.19 Billion CNY

Based on the latest financial reports, Hubei Huaqiang High-Tech Co. Ltd. A (688151) has net assets worth CN¥4.19 Billion CNY as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.82 Billion) and total liabilities (CN¥631.74 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CN¥4.19 Billion
% of Total Assets 86.9%
Annual Growth Rate 34.6%
5-Year Change 262.65%
10-Year Change N/A
Growth Volatility 104.44

Hubei Huaqiang High-Tech Co. Ltd. A - Net Assets Trend (2019–2024)

This chart illustrates how Hubei Huaqiang High-Tech Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Hubei Huaqiang High-Tech Co. Ltd. A (2019–2024)

The table below shows the annual net assets of Hubei Huaqiang High-Tech Co. Ltd. A from 2019 to 2024.

Year Net Assets Change
2024-12-31 CN¥4.20 Billion +0.71%
2023-12-31 CN¥4.17 Billion -0.41%
2022-12-31 CN¥4.19 Billion -1.07%
2021-12-31 CN¥4.23 Billion +265.49%
2020-12-31 CN¥1.16 Billion +21.90%
2019-12-31 CN¥950.04 Million --

Equity Component Analysis

This analysis shows how different components contribute to Hubei Huaqiang High-Tech Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 53.5% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CN¥247.61 Million 5.90%
Other Components CN¥3.95 Billion 94.10%
Total Equity CN¥4.20 Billion 100.00%

Hubei Huaqiang High-Tech Co. Ltd. A Competitors by Market Cap

The table below lists competitors of Hubei Huaqiang High-Tech Co. Ltd. A ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Hubei Huaqiang High-Tech Co. Ltd. A's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 4,170,259,797 to 4,199,776,758, a change of 29,516,961 (0.7%).
  • Net income of 22,527,857 contributed positively to equity growth.
  • Dividend payments of 8,199,100 reduced retained earnings.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CN¥22.53 Million +0.54%
Dividends Paid CN¥8.20 Million -0.2%
Other Changes CN¥15.19 Million +0.36%
Total Change CN¥- 0.71%

Book Value vs Market Value Analysis

This analysis compares Hubei Huaqiang High-Tech Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.80x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 5.95x to 1.80x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 CN¥3.68 CN¥21.90 x
2020-12-31 CN¥4.48 CN¥21.90 x
2021-12-31 CN¥12.29 CN¥21.90 x
2022-12-31 CN¥12.15 CN¥21.90 x
2023-12-31 CN¥12.11 CN¥21.90 x
2024-12-31 CN¥12.19 CN¥21.90 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Hubei Huaqiang High-Tech Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.54%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 3.68%
  • • Asset Turnover: 0.13x
  • • Equity Multiplier: 1.16x
  • Recent ROE (0.54%) is below the historical average (6.47%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 13.69% 7.90% 0.75x 2.32x CN¥35.07 Million
2020 15.21% 21.10% 0.36x 2.00x CN¥60.39 Million
2021 7.54% 25.04% 0.24x 1.25x CN¥-104.08 Million
2022 1.63% 11.62% 0.11x 1.23x CN¥-350.65 Million
2023 0.19% 1.38% 0.11x 1.21x CN¥-409.10 Million
2024 0.54% 3.68% 0.13x 1.16x CN¥-397.45 Million

Industry Comparison

This section compares Hubei Huaqiang High-Tech Co. Ltd. A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $2,246,530,775
  • Average return on equity (ROE) among peers: 12.28%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Hubei Huaqiang High-Tech Co. Ltd. A (688151) CN¥4.19 Billion 13.69% 0.15x $241.61 Million
Beijing Centergate Technologies Holding Co Ltd (000931) $2.03 Billion -9.26% 2.64x $356.80 Million
Blue Sail Medical Co Ltd (002382) $10.54 Billion 10.97% 0.61x $763.05 Million
Andon Health Co Ltd (002432) $758.75 Million 1.34% 0.32x $2.12 Billion
Allmed Medical Products Co Ltd Class A (002950) $2.75 Billion 15.67% 0.82x $346.13 Million
Guangzhou Improve Med Instrument (300030) $592.55 Million 4.90% 0.10x $234.74 Million
Shanghai Tofflon Science Tech (300171) $2.41 Billion 11.06% 0.57x $784.88 Million
Truking Technology Ltd (300358) $320.32 Million 29.77% 1.35x $545.42 Million
Jiangxi Sanxin Medtec Co Ltd (300453) $1.41 Billion 16.14% 0.58x $438.45 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573) $1.55 Billion 13.64% 0.15x $1.62 Billion
Autek China Inc (300595) $105.24 Million 28.59% 0.10x $1.21 Billion